Journal article
Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial
Measles is a highly infectious respiratory disease which causes 122,000 deaths annually. Although measles vaccine is extremely safe and effective, vaccine coverage could be improved by a vaccine that is more easily administered and transported. The researchers developed an inhalable dry powder measles vaccine (MVDP) and two delivery devices, and demonstrated safety, immunogenicity, and efficacy of the vaccine in preclinical studies. Here they report the first clinical trial of MVDP delivered by inhalation.
Authors
Languages
- English
Publication year
2014
Journal
Vaccine
Volume
32
Issue
50
Type
Journal article
Categories
- Vaccines & delivery devices
Diseases
- Measles
